200 related articles for article (PubMed ID: 16948517)
1. CD10 expression in cutaneous adnexal neoplasms and a potential role for differentiating cutaneous metastatic renal cell carcinoma.
Bahrami S; Malone JC; Lear S; Martin AW
Arch Pathol Lab Med; 2006 Sep; 130(9):1315-9. PubMed ID: 16948517
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical study of calretinin in normal skin and cutaneous adnexal proliferations.
González-Guerra E; Kutzner H; Rutten A; Requena L
Am J Dermatopathol; 2012 Jul; 34(5):491-505. PubMed ID: 22343111
[TBL] [Abstract][Full Text] [Related]
3. GATA3 and MYB Expression in Cutaneous Adnexal Neoplasms.
Pardal J; Sundram U; Selim MA; Hoang MP
Am J Dermatopathol; 2017 Apr; 39(4):279-286. PubMed ID: 28323779
[TBL] [Abstract][Full Text] [Related]
4. Her-2 expression in cutaneous eccrine and apocrine neoplasms.
Hiatt KM; Pillow JL; Smoller BR
Mod Pathol; 2004 Jan; 17(1):28-32. PubMed ID: 14631375
[TBL] [Abstract][Full Text] [Related]
5. Benign cutaneous adnexal tumors with combined folliculosebaceous, apocrine, and eccrine differentiation. Clinicopathologic and immunohistochemical study of eight cases.
Wong TY; Suster S; Cheek RF; Mihm MC
Am J Dermatopathol; 1996 Apr; 18(2):124-36. PubMed ID: 8739986
[TBL] [Abstract][Full Text] [Related]
6. Staining of eccrine and apocrine neoplasms and metastatic adenocarcinoma with IKH-4, a monoclonal antibody specific for the eccrine gland.
Ishihara M; Mehregan DR; Hashimoto K; Yotsumoto S; Toi Y; Pietruk T; Mehregan AH; Mehregan DA
J Cutan Pathol; 1998 Feb; 25(2):100-5. PubMed ID: 9521499
[TBL] [Abstract][Full Text] [Related]
7. Expression of Bcl-x in normal skin and benign cutaneous adnexal tumors.
Thamboo TP; Tan LH; Tan SY
J Cutan Pathol; 2006 Jan; 33(1):27-32. PubMed ID: 16441408
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous PEComas Express CD10: Implications for the Classification of PEComas and the Differential Diagnosis With Metastatic Renal Cell Carcinoma.
Fernandez-Flores A; Nguyen CM; Cassarino DS
Am J Dermatopathol; 2016 Sep; 38(9):645-52. PubMed ID: 26909587
[TBL] [Abstract][Full Text] [Related]
9. The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases.
Pan CC; Chen PC; Ho DM
Histopathology; 2004 Nov; 45(5):452-9. PubMed ID: 15500648
[TBL] [Abstract][Full Text] [Related]
10. Current Diagnosis and Treatment Options for Cutaneous Adnexal Neoplasms with Apocrine and Eccrine Differentiation.
Płachta I; Kleibert M; Czarnecka AM; Spałek M; Szumera-Ciećkiewicz A; Rutkowski P
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34064849
[TBL] [Abstract][Full Text] [Related]
11. [Benign adnexal skin tumors].
Rudolph P
Pathologe; 2002 Jan; 23(1):71-8. PubMed ID: 11974506
[TBL] [Abstract][Full Text] [Related]
12. The expression of CD23 in cutaneous non-lymphoid neoplasms.
Carvalho J; Fullen D; Lowe L; Su L; Ma L
J Cutan Pathol; 2007 Sep; 34(9):693-8. PubMed ID: 17696916
[TBL] [Abstract][Full Text] [Related]
13. Expression of androgen receptors in skin appendage tumors: an immunohistochemical study.
Shikata N; Kurokawa I; Andachi H; Tsubura A
J Cutan Pathol; 1995 Apr; 22(2):149-53. PubMed ID: 7560348
[TBL] [Abstract][Full Text] [Related]
14. An immunohistochemical study of lysozyme, CD-15 (Leu M1), and gross cystic disease fluid protein-15 in various skin tumors. Assessment of the specificity and sensitivity of markers of apocrine differentiation.
Ansai S; Koseki S; Hozumi Y; Kondo S
Am J Dermatopathol; 1995 Jun; 17(3):249-55. PubMed ID: 8599433
[TBL] [Abstract][Full Text] [Related]
15. Expression of CD10 in basal cell carcinoma.
Yada K; Kashima K; Daa T; Kitano S; Fujiwara S; Yokoyama S
Am J Dermatopathol; 2004 Dec; 26(6):463-71. PubMed ID: 15618927
[TBL] [Abstract][Full Text] [Related]
16. Chondroid syringoma. Cytokeratin 20 immunolocalization of Merkel cells and reappraisal of apocrine folliculo-sebaceous differentiation.
Salama ME; Azam M; Ma CK; Ormsby A; Zarbo RJ; Amin MB; Lee MW
Arch Pathol Lab Med; 2004 Sep; 128(9):986-90. PubMed ID: 15335266
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemistry for CD117 (KIT) is effective in distinguishing cutaneous adnexal tumors with apocrine/eccrine or sebaceous differentiation from other epithelial tumors of the skin.
Goto K
J Cutan Pathol; 2015 Jul; 42(7):480-8. PubMed ID: 25864700
[TBL] [Abstract][Full Text] [Related]
18. Induction of cutaneous hyperplasias by altered stroma.
Requena L; Yus ES; Simón P; del Rio E
Am J Dermatopathol; 1996 Jun; 18(3):248-68. PubMed ID: 8806959
[No Abstract] [Full Text] [Related]
19. Eccrine or apocrine poroma? Six poromas with divergent adnexal differentiation.
Harvell JD; Kerschmann RL; LeBoit PE
Am J Dermatopathol; 1996 Feb; 18(1):1-9. PubMed ID: 8721584
[TBL] [Abstract][Full Text] [Related]
20. Benign ocular adnexal tumours of apocrine, eccrine or hair follicle origin.
Ozdal PC; Callejo SA; Codère F; Burnier MN
Can J Ophthalmol; 2003 Aug; 38(5):357-63. PubMed ID: 12956276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
